141 related articles for article (PubMed ID: 11118024)
41. Association of tumor necrosis factor (TNF) promoter polymorphisms with plasma TNF-α levels and susceptibility to diabetic nephropathy in North Indian population.
Gupta S; Mehndiratta M; Kalra S; Kalra OP; Shukla R; Gambhir JK
J Diabetes Complications; 2015 Apr; 29(3):338-42. PubMed ID: 25704106
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein E genotypes and risk of diabetic nephropathy.
Onuma T; Laffel LM; Angelico MC; Krolewski AS
J Am Soc Nephrol; 1996 Jul; 7(7):1075-8. PubMed ID: 8829124
[TBL] [Abstract][Full Text] [Related]
43. Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect.
Mlynarski WM; Placha GP; Wolkow PP; Bochenski JP; Warram JH; Krolewski AS
Diabetes; 2005 Nov; 54(11):3331-5. PubMed ID: 16249462
[TBL] [Abstract][Full Text] [Related]
44. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes.
Canani LH; Costa LA; Crispim D; Gonçalves Dos Santos K; Roisenberg I; Lisbôa HR; Sarturi Tres G; Maia AL; Gross JL
Diabet Med; 2005 Sep; 22(9):1167-72. PubMed ID: 16108844
[TBL] [Abstract][Full Text] [Related]
45. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis.
Moczulski DK; Rogus JJ; Antonellis A; Warram JH; Krolewski AS
Diabetes; 1998 Jul; 47(7):1164-9. PubMed ID: 9648845
[TBL] [Abstract][Full Text] [Related]
46. Association between the vitamin D receptor gene polymorphisms and diabetic nephropathy risk: A meta-analysis.
Yin F; Liu J; Fan MX; Zhou XL; Zhang XL
Nephrology (Carlton); 2018 Feb; 23(2):107-116. PubMed ID: 28703918
[TBL] [Abstract][Full Text] [Related]
47. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
48. Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies.
Yin YW; Qiao L; Sun QQ; Hu AM; Liu HL; Wang Q; Hou ZZ
Metabolism; 2014 Apr; 63(4):532-41. PubMed ID: 24439487
[TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes.
Tien KJ; Tu ST; Chou CW; Yang CY; Hsiao JY; Shin SJ; Chen HC; Hsieh MC
Am J Nephrol; 2011; 33(3):231-8. PubMed ID: 21346330
[TBL] [Abstract][Full Text] [Related]
50. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
51. Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations.
Hadjadj S; Tarnow L; Forsblom C; Kazeem G; Marre M; Groop PH; Parving HH; Cambien F; Tregouet DA; Gut IG; Théva A; Gauguier D; Farrall M; Cox R; Matsuda F; Lathrop M; Hager-Vionnet N;
J Am Soc Nephrol; 2007 Apr; 18(4):1284-91. PubMed ID: 17376814
[TBL] [Abstract][Full Text] [Related]
52. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients.
Santos KG; Canani LH; Gross JL; Tschiedel B; Souto KE; Roisenberg I
J Nephrol; 2005; 18(6):733-8. PubMed ID: 16358232
[TBL] [Abstract][Full Text] [Related]
53. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy.
Eto M; Horita K; Morikawa A; Nakata H; Okada M; Saito M; Nomura M; Abiko A; Iwashima Y; Ikoda A
Clin Genet; 1995 Dec; 48(6):288-92. PubMed ID: 8835322
[TBL] [Abstract][Full Text] [Related]
54. The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.
Li T; Shi Y; Yin J; Qin Q; Wei S; Nie S; Liu L
Int Urol Nephrol; 2015 Jan; 47(1):117-30. PubMed ID: 25262148
[TBL] [Abstract][Full Text] [Related]
55. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
Yu ZY; Chen LS; Zhang LC; Zhou TB
Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
[TBL] [Abstract][Full Text] [Related]
56. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms in oxidative stress pathway genes and risk of diabetic nephropathy in South Indian type 2 diabetic patients.
Narne P; Ponnaluri KC; Siraj M; Ishaq M
Nephrology (Carlton); 2014 Oct; 19(10):623-9. PubMed ID: 25041504
[TBL] [Abstract][Full Text] [Related]
58. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
[TBL] [Abstract][Full Text] [Related]
59. Novel sequence variants in the human xylosyltransferase I gene and their role in diabetic nephropathy.
Bahr C; Schön S; Kuhn J; Groop PH; Parkkonen M; Wessman M; Kleesiek K; Götting C
Diabet Med; 2006 Jun; 23(6):681-4. PubMed ID: 16759312
[TBL] [Abstract][Full Text] [Related]
60. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
Lajer M; Tarnow L; Fleckner J; Hansen BV; Edwards DG; Parving HH; Boel E
Diabet Med; 2004 Aug; 21(8):867-73. PubMed ID: 15270790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
